Droperidol
Back to searchMolecule Structure
Scientific Name
Droperidol
Description of the Drug
Droperidol is a butyrophenone derivative and dopamine antagonist used to prevent and treat postoperative nausea and vomiting.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00450
http://www.drugbank.ca/drugs/DB00450
Brand Name(s)
Dridol, Droleptan, Droperidol, Inapsine
Company Owner(s)
Watson Laboratories Inc, American Regent Inc, Igi Laboratories Inc, Abraxis Pharmaceutical Products, Solopak Laboratories Inc, Hospira Inc, Astrazeneca Lp, Luitpold Pharmaceuticals Inc, Akorn Operating Co Llc, Eurohealth International Sarl
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2331075 |
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL41426 |
| PharmGKB | PA449422 |
| Human Metabolome Database | HMDB0014593 |
| WDI | DROPERIDO |
| DrugBank | DB00450 |
| PubChem: Thomson Pharma | 14780048 |
| PubChem | 3168 |
| LINCS | LSM-4193 |
| Nikkaji | J26.622A |
| PDBe | USS |
| BindingDB | 50017705 |
| EPA CompTox Dashboard | DTXSID6022973 |
| DrugCentral | 966 |
| Brenda | 217393 |
| ChemicalBook | CB9145418 |
| Guide to Pharmacology | 7172 |
| GSRS | 0d119967-5dac-418a-8bcb-6b2de6dfe87e |
| rxnorm | DROPERIDOL |
| ChEBI | 4717 |
| NIH Clinical Collection | SAM001247013 |
| ZINC | ZINC000019796080 |
